Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma

A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome

(2011) E. D. Jacobsen et al.   ANNALS OF ONCOLOGY

90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma

(2011) A. K. Gopal et al.   BLOOD

Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications

(2011) Joseph Pidala et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

(2011) Roel J.W. van Kampen et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

(2011) John R. Wingard et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

(2011) Jasmine Zain et al.   LEUKEMIA & LYMPHOMA

Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type

(2011) Daisuke Ennishi et al.   LEUKEMIA & LYMPHOMA

Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias

(2010) Zachariah McIver et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

(2010) David L. Porter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation

(2010) Vincent T. Ho et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)

(2010) Asad Bashey et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review

(2010) Denise M. Oliansky et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rethinking warfarin reversal

(2010) D. Garcia   BLOOD

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

(2010) J. R. Lambert et al.   BLOOD

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

(2010) M. Hishizawa et al.   BLOOD

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT

(2010) M-A Perales et al.   BONE MARROW TRANSPLANTATION

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transp

(2010) Anna Dodero et al.   CANCER

Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia

(2010) Yok-Lam Kwong   INTERNATIONAL JOURNAL OF HEMATOLOGY

Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2010) Rafael F. Duarte et al.   JOURNAL OF CLINICAL ONCOLOGY

Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome

(2010) Madeleine Duvic et al.   JOURNAL OF CLINICAL ONCOLOGY

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

(2010) Christian Gisselbrecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study

(2010) K S Baker et al.   LEUKEMIA

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence

(2010) Koen van Besien et al.   LEUKEMIA & LYMPHOMA

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

(2010) Irene Cavattoni et al.   LEUKEMIA & LYMPHOMA

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

(2010) Vaishalee P. Kenkre et al.   LEUKEMIA & LYMPHOMA

Allogeneic hematopoietic stem cell transplant following chemotherapy containingl-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type

(2010) Hisayuki Yokoyama et al.   LEUKEMIA & LYMPHOMA

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

(2009) Peggy A. Wu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Promising Progression-Free Survival for Patients Low and Intermediate Grade Lymphoid Malignancies after Nonmyeloablative Umbilical Cord Blood Transplantation

(2009) Claudio G. Brunstein et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research

(2009) Sergio Giralt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents

(2009) Thomas G. Gross et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR

(2009) Hillard M. Lazarus et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

(2009) Anne Sirvent et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

(2009) N. A. Johnson et al.   BLOOD

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

(2009) K. J. Savage et al.   BLOOD

Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma

(2009) Michael R. Bishop et al.   CANCER

Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2009) Charalampia Kyriakou et al.   JOURNAL OF CLINICAL ONCOLOGY

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation

(2009) L Farina et al.   LEUKEMIA

Paucity of HLA-Identical Unrelated Donors for African-Americans with Hematologic Malignancies: The Need for New Donor Options

(2008) Alexander Dew et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Second Autologous Stem Cell Transplantation for Relapsed Lymphoma after a Prior Autologous Transplant

(2008) Sonali M. Smith et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome

(2008) Philippe Armand et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Similar and Promising Outcomes in Lymphoma Patients Treated with Myeloablative or Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

(2008) Marcie Tomblyn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL): Clinical Impact of Graft-versus-Leukemia/Lymphoma Effect

(2008) Souichi Shiratori et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

(2008) Andrew R. Rezvani et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

(2008) Mohamed Sorror et al.   CANCER

Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning

(2008) Philippe Armand et al.   JOURNAL OF CLINICAL ONCOLOGY

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

(2008) Steven Le Gouill et al.   JOURNAL OF CLINICAL ONCOLOGY

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

(2008) Kirsty J. Thomson et al.   JOURNAL OF CLINICAL ONCOLOGY

Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma

(2007) Peter Dreger et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION